The postdoctoral fellow position is part of a T32 Training Program partnership between UT MD Anderson Cancer Center and Rice University.
The program is geared toward young scientists who aim to pursue integrated; translational research focused on advancing promising new nanotechnology-based diagnostics and therapeutics to improve cancer care. The fellows will commit much of their time to research and technical training, with the course participation accounting for no more than 10% of their effort. The research projects will be clinically and biologically relevant to cancer and will examine nanoscience and nanotechnology as potential solutions. A detailed mentoring plan will also be developed for each fellow that includes project aims and multidisciplinary coursework, and seminar experiences.
The main goal of this T32 training program is to educate future leaders in the broad field of nanotechnology with specific interests in cancer-related applications, which are keenly aware of the needs and demands of a clinical environment and the major challenges of translational research. After completing this program, the trainees will be able to demonstrate the ability to carry out independent translational research in cancer nanotechnology. Didactic coursework will prepare them to contribute to research projects that directly address barriers to the translation of nanotechnology-based approaches and to develop the skills needed to define and lead such projects. Trainees will develop a foundational background in the field by taking at least four didactical courses related to translational cancer or nanotechnology topics. Trainees will gain essential writing skills through scientific writing seminars and by writing an NIH grant proposal. Finally, trainees will gain critical lab management skills by participating in a short hands-on course introducing laboratory and project management.
Per the T32 program requirement, qualified postdoctoral fellows "must be citizens or noncitizen nationals of the United States or have been lawfully admitted for permanent residence at the time of appointment."
Candidates should have recently completed (within three years) Ph.D. training in physical science, chemistry, or bioengineering with a demonstrated background and interest in nanotechnology. Holders of an M.D. degree will be eligible for the program if they show a strong interest in translational cancer nanotechnology research.
Preferred Experience: Candidates with training in physical science, chemistry, or bioengineering with a demonstrated background and interest in nanotechnology. Candidates with M.D. degrees may be eligible for the program if they show a strong interest in translational cancer nanotechnology research.
ADDITIONAL APPLICATION INFORMATION
Applicants must include their GPA on their CV to be considered for this position
Dr. Konstantin Sokolov